Alembic Pharmaceuticals’s subsidiary, Aleor Dermaceuticals, has received Establishment Inspection Report (EIR) from the USFDA for the inspection carried out at Karakhadi, Gujarat, during September. The stock was up 0.8%.
Alembic Pharmaceuticals gains 3% on zero observations from USFDA USFDA inspected Vadodara facility between August 12, 2019 to August 20, 2019 for Bioequivalence Bioanalytical and Bioequivalence Clinical.
Stocks in the news: SPARC, SpiceJet, Alembic Pharma, Dr Reddys Labs, United Spirits, Deepak Nitrite Alembic Pharma | Dr Reddy's Labs | United Spirits | HDIL | Deepak Nitrite | IOL Chemicals and Freshtrop Fruits are stocks which are in the news today.
Alembic Pharma gets USFDA nod for cholesterol lowering drug The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets in the strengths of 48 mg and 145 mg, Alembic Pharmaceuticals said in a BSE filing.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.